Published Date: 16 Feb 2023
According to a report by the Alzheimer's Association task force, it's time to reframe what "clinically meaningful" means and change expectations about clinical trials.
Read Full NewsThis rheumatology month in review emphasizes new data and impactful approvals.
The Q4 recap for rheumatology spotlights regulatory and clinical advances across rheumatic diseases.
A trio of clinician authors provided insights on a recently published paper assessing youths with refractory epilepsy and ways to combat depressive symptoms.
The FDA approved Sentynl Therapeutics’ copper histidinate for the treatment of pediatric Menkes disease, a rare genetic neurodegenerative disorder, following an earlier complete response letter.
Annette Lenger-Gould, MD, PhD, lead for clinical and translational neuroscience at Kaiser Permanente, discusses findings and significance from a recently published trial assessing rituximab in patients with relapsing multiple sclerosis.
The senior director of the Fluid Biomarker Program at Banner Health highlighted the evolving role of blood and fluid biomarkers in Alzheimer disease research and clinical practice.
The European Commission approved Biogen’s high-dose nusinersen regimen for 5q SMA, supported by DEVOTE trial data showing significantly improved motor function with a safety profile consistent with the standard-dose regimen.
1.
Advanced breast cancer patients living longer thanks to improvements in treatment and care
2.
Decrease seen in in situ breast cancer since 2009
3.
Appropriate New Monoclonal for Immunocompromised Individuals to Prevent COVID-19.
4.
AI is useful in low-resource areas for triaging breast masses.
5.
When performed by skilled surgeons, robotic surgery for pancreatic tumors is safe and feasible.
1.
Uncovering New Hope for Follicular Lymphoma Patients
2.
Radiation in Oncology: Advances, Applications, and Accessibility
3.
What Is Degos Disease? A Comprehensive Overview Of Symptoms, Diagnosis, and Treatment
4.
Case Study: Advancing Preclinical Oncology Drug Development with Quantitative Systems Pharmacology
5.
A Revolutionary Guide to Calculating Absolute Neutrophil Counts
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
2.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part II
3.
Understanding the causes of anemia in adults beyond nutritional deficiencies
4.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII
5.
Nimotozumab Plus Chemo-radiotherapy v/s Placebo Plus Chemo-radiotherapy in Locally Advanced Nasopharyngeal Carcinoma
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation